Patent · US Active

Crystalline form of sacubitril sodium salt

US10683260B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

Nanjing Noratech Pharmaceuticals Co., LTD · CN

Inventors

Fei Liu · Nanjing, CN
Gang Wu · Zhejiang, CN
Weiming Jiang · Nanjing, CN
Cheng-Gang LIN · Nanjing, CN
Xuan Cai · Nanjing, CN
Ping Lin · Qingdao, CN
Yuling Lu · Nanjing, CN
Lixiang Liu · Chengdu, CN

Key dates

Filing date	Sep 7, 2016
Grant date	Jun 16, 2020
Priority date	—
Expiry date	Sep 7, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are new crystalline forms A, B, C, D and E of sacubitril sodium salt and a method for preparation thereof, pharmaceutical compositions thereof, and application thereof in preparing drugs for enkephalinase-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.